OPEN END TURBO PUT WARRANT - PFIZER INC | Delayed Deutsche Boerse AG 09:56:44 13/06/2024 pm IST | ||
| 3.35 EUR | +1.52% |
|
| Current month | +1.85% | ||
| 1 month | +0.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 13/24/13 | 3.35 | +1.52% |
| 12/24/12 | 3.3 | -0.30% |
| 11/24/11 | 3.31 | +0.30% |
| 10/24/10 | 3.3 | +2.48% |
| 07/24/07 | 3.22 | +0.94% |
Delayed Quote Deutsche Boerse AG
Last update June 13, 2024 at 09:56 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | UBS |
| WKN | UH5R35 |
| ISIN | DE000UH5R357 |
| Date issued | 17/12/2021 |
| Strike | 63.34 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.01 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.63 € |
|---|---|
| Lowest since issue | 0.77 € |
| Spread | 0.01 € |
| Spread % | 0.30% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.66
USD
Average target price
31.92
USD
Spread / Average Target
+15.38%
- Stock Market
- Certificates
- Certificat
